David Chauvin
About David Chauvin
David Chauvin is a Research and Development Scientist at Aridis Pharmaceuticals, specializing in the development of anti-infectious therapeutic antibodies. He holds a PhD in immunotherapy applied to mycology and has a strong technical background in infectiology and immunotherapy.
Work at Aridis Pharmaceuticals
David Chauvin has been employed at Aridis Pharmaceuticals as a Research and Development Scientist since 2019. His role involves the development of anti-infectious therapeutic antibodies, contributing to the company's efforts in advancing innovative treatments. Located in Los Gatos, California, he has been part of the team for five years, focusing on research that aligns with Aridis Pharmaceuticals' mission to address unmet medical needs in infectious diseases.
Education and Expertise
David Chauvin holds a Doctor of Philosophy (PhD) in immunotherapy applied to mycology, which he earned from Université de Tours from 2015 to 2018. He also completed a Master of Science (MS) in Cellular and Molecular Infectiology, Vaccinology, and Therapeutic antibodies at the same institution from 2013 to 2015. His academic background includes a Bachelor of Science (BS) in Cellular Biology, Genetics, Microbiology, and Animal Physiology from Université de Rennes I, as well as another BS in Biotechnologies Applied to Health from Université de Reims Champagne-Ardenne.
Background
David Chauvin's educational journey began with a BTEC Higher National Diploma in Bio-Analysis and Quality Control from Lycée Jean Macé de Lanester, completed from 2009 to 2011. He then pursued further studies in various biological sciences, culminating in advanced degrees that provided a strong foundation in infectiology and immunotherapy. His diverse educational experiences have equipped him with a comprehensive understanding of the biological sciences.
Specialization in Therapeutic Antibodies
David Chauvin specializes in the development of anti-infectious therapeutic antibodies. His expertise in this area is supported by his extensive education and research experience in immunotherapy and infectiology. This specialization plays a crucial role in his work at Aridis Pharmaceuticals, where he contributes to the development of innovative therapeutic solutions aimed at combating infectious diseases.